Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDIGC Pharma Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.03 | -$0.03 | -$0.03 |
| Q2 2026 | 1 | -$0.02 | -$0.02 | -$0.02 |
| Q3 2026 | 1 | -$0.02 | -$0.02 | -$0.02 |
| Q4 2026 | 1 | -$0.03 | -$0.03 | -$0.03 |
| Q1 2027 | 1 | -$0.03 | -$0.03 | -$0.03 |
| Q2 2027 | 1 | -$0.02 | -$0.02 | -$0.02 |
| Q3 2027 | 1 | -$0.02 | -$0.02 | -$0.02 |
| Q4 2027 | 1 | -$0.02 | -$0.02 | -$0.02 |
IGC Pharma Inc Earnings Date And Information
IGC Pharma Inc last posted its earnings results on Friday, April 3rd, 2026. The company reported $-0.01 earnings per share for the quarter, topping analysts' consensus estimates of $-0.02 by $0.01. The company had revenue of 350.00 K for the quarter and had revenue of 1.27 M for the year. IGC Pharma Inc has generated $0 earnings per share over the last year ($-0.0931 diluted earnings per share) and currently has a price-to-earnings ratio of -5.27. IGC Pharma Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
IGC Pharma Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 12/30/2025 | Q3 2026 | N/A | -$0.01 | N/A | $198.00 K | $350.00 K |
| 11/14/2025 | Q2 2026 | -$0.02 | -$0.02 | 0 | $383.00 K | $191.00 K |
| 08/14/2025 | Q1 2026 | -$0.03 | -$0.02 | 0.01 | $326.00 K | $328.00 K |
| 06/27/2025 | Q4 2025 | -$0.02 | -$0.02 | 0 | $305.00 K | $330.00 K |
| 02/14/2025 | Q3 2025 | -$0.03 | -$0.02 | 0.01 | $204.00 K | $257.00 K |
| 11/12/2024 | Q2 2025 | -$0.02 | -$0.02 | -0.01 | $291.00 K | $412.00 K |
| 08/07/2024 | Q1 2025 | N/A | -$0.03 | N/A | $450.00 K | $272.00 K |
| 06/24/2024 | Q4 2024 | -$0.00 | -$0.04 | -0.04 | $193.00 K | $295.00 K |
| 02/14/2024 | Q3 2024 | -$0.04 | -$0.09 | -0.05 | N/A | $204.00 K |
| 11/09/2023 | Q2 2024 | N/A | -$0.05 | N/A | N/A | $291.00 K |
| 08/10/2023 | Q1 2024 | N/A | -$0.04 | N/A | N/A | $555.00 K |
| 07/07/2023 | Q4 2023 | N/A | -$0.08 | N/A | N/A | $166.00 K |
| 02/14/2023 | Q3 2023 | N/A | -$0.04 | N/A | N/A | $332.00 K |
| 11/01/2022 | Q2 2023 | N/A | -$0.05 | N/A | N/A | $202.00 K |
| 08/05/2022 | Q1 2023 | N/A | -$0.05 | N/A | N/A | $212.00 K |
| 06/22/2022 | Q4 2022 | N/A | -$0.16 | N/A | N/A | $122.00 K |
| 02/10/2022 | Q3 2022 | N/A | -$0.05 | N/A | N/A | $142.00 K |
| 10/29/2021 | Q2 2022 | N/A | -$0.09 | N/A | N/A | $56.00 K |
| 08/11/2021 | Q1 2022 | N/A | -$0.04 | N/A | N/A | $77.00 K |
| 06/14/2021 | Q4 2021 | N/A | -$0.07 | N/A | N/A | $81.00 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
IGC Pharma Inc Earnings: FAQ's
In the previous quarter, IGC Pharma Inc (:IGC) reported $-0.01 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.02 by $0.01.
The conference call for IGC Pharma Inc's latest earnings report can be listened to online.
The conference call transcript for IGC Pharma Inc's latest earnings report can be read online.
IGC Pharma Inc (:IGC) has a recorded annual revenue of $1.27 M.
IGC Pharma Inc (:IGC) has a recorded net income of $-7,121,000.IGC Pharma Inc has generated $-0.0931 earnings per share over the last four quarters.
IGC Pharma Inc (:IGC) has a price-to-earnings ratio of -5.27 and price/earnings-to-growth ratio is -0.07.